DIGITAL EDITION

ARCHIVES

Tag: blood brain barrier

Blood–Brain Barrier: COVID-19, Pandemics, and Cytokine Norms

by Atmaram Yarlagadda, MD; Samuel L. Preston, DO; Rachel P. Jeyadhas, MD; Adam Edward Lang, PharmD; Rasha Hammamieh, PhD; And Anita H. Clayton, MD Dr. Yarlagadda is the Installation Director

It’s Time for Combination Therapies in Multiple Sclerosis

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40.

The Blood Brain Barrier and the Role of Cytokines in Neuropsychiatry

by Atmaram Yarlagadda, MD; Elizabeth Alfson, BA; and Anita H. Clayton, MD Dr. Yarlagadda is from Newport News, Virginia, Ms. Alfson is from Charlottesville, Virginia, and Dr. Clayton is Professor,

Thermoregulation and the Role of Calcium Signalling in Neurotransmission

by Atmaram Yarlagadda, MD, and Anita H. Clayton, MD Dr. Yarlagadda is from Newport News, Virginia, and Dr. Clayton is Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia,